Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia
Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; School of Medicine, University of Belgrade, Belgrade, Serbia
Kardiol Pol. 2020 Mar 25;78(3):209-218. doi: 10.33963/KP.15187. Epub 2020 Feb 12.
An incidental lesion of the parasympathetic ganglia during circumferential pulmonary vein isolation (CPVI) may affect heart rate variability (HRV).
We studied the pattern of changes in HRV parameters and the relationship between the 1‑year HRV change following CPVI and the recurrence of atrial fibrillation (AF).
A total of 100 consecutive patients undergoing CPVI for paroxysmal AF were enrolled (mean [SD] age, 56 [11.2] years; 61 men). We measured HRV on the day before and after CPVI, and then at 1 month as well as 3, 6, and 12 months after CPVI using 24‑hour Holter monitoring.
During the median follow‑up of 33 months, 38 patients experienced the late recurrence of AF (LRAF). Compared with the pre‑CPVI values, HRV was significantly attenuated on day 1 after CPVI in all patients. However, at 3 to 6 months after CPVI, all HRV parameters remained significantly decreased in LRAF‑free patients but not in those with LRAF. The multivariate Cox analysis showed that early AF recurrence within the blanking period (hazard ratio [HR], 4.87; 95% CI, 2.44–9.69; P <0.001) and a change in the standard deviation of normal‑to‑normal intervals (SDNN) observed 3 months after ablation (HR, 0.99; 95% CI, 0.98–1; P = 0.01) were associated with LRAF. The cumulative LRAF freedom after CPVI was greater in patients with an SDNN reduction of more than 25 ms reported 3 months after ablation than in those with a reduction of 25 ms or lower (log‑rank P = 0.004).
Sustained parasympathetic denervation during 12 months after CPVI was a marker of successful CPVI, whereas a 3‑month post‑CPVI SDNN reduction of 25 ms or lower predicted LRAF.
在环形肺静脉隔离(CPVI)过程中,副交感神经节的偶然损伤可能会影响心率变异性(HRV)。
我们研究了 HRV 参数变化模式以及 CPVI 后 1 年 HRV 变化与心房颤动(AF)复发之间的关系。
共纳入 100 例接受 CPVI 治疗阵发性 AF 的连续患者(平均[标准差]年龄 56[11.2]岁;61 例男性)。我们使用 24 小时动态 Holter 监测在 CPVI 前、后 1 天以及 CPVI 后 1、3、6 和 12 个月测量 HRV。
在中位 33 个月的随访期间,38 例患者发生晚期 AF 复发(LRAF)。与 CPVI 前值相比,所有患者 CPVI 后 1 天 HRV 明显减弱。然而,在 CPVI 后 3 至 6 个月时,LRAF 无复发患者的所有 HRV 参数仍明显降低,但 LRAF 患者则没有。多变量 Cox 分析显示,空白期内早期 AF 复发(危险比[HR],4.87;95%置信区间,2.44-9.69;P<0.001)和消融后 3 个月观察到的正常-正常间期标准差(SDNN)变化(HR,0.99;95%置信区间,0.98-1;P=0.01)与 LRAF 相关。与 SDNN 降低 25 毫秒或以下的患者相比,消融后 3 个月报告 SDNN 降低超过 25 毫秒的患者 CPVI 后 LRAF 自由的累积率更高(对数秩 P=0.004)。
CPVI 后 12 个月持续的副交感神经去神经支配是 CPVI 成功的标志物,而 CPVI 后 3 个月 SDNN 降低 25 毫秒或更低预测 LRAF。